# Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis

Study · id `cardio:ct-nct01252420` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01252420](<https://clinicaltrials.gov/study/NCT01252420>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01252420

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 330 participants.

## Technical summary

Registry record NCT01252420. Allocation not applicable; no masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2013-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 330 participants (planned count; ClinicalTrials.gov record NCT01252420, source copy `cardio:ctgov-nct01252420-2010-12-06`, retrieved 2026-10-31)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01252420, source copy `cardio:ctgov-nct01252420-2010-12-06`, retrieved 2026-10-31)
- Primary completion: 2013-11 (anticipated) (ClinicalTrials.gov record NCT01252420, source copy `cardio:ctgov-nct01252420-2010-12-06`, retrieved 2026-10-31)
- Completion: 2014-11 (anticipated) (ClinicalTrials.gov record NCT01252420, source copy `cardio:ctgov-nct01252420-2010-12-06`, retrieved 2026-10-31)
- Countries: Australia; New Zealand (ClinicalTrials.gov record NCT01252420, source copy `cardio:ctgov-nct01252420-2010-12-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01252420-2010-12-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
- Acronym: TWISTER
- Condition: Venous Thrombosis
- Condition: Pulmonary Embolism
- Intervention (Drug): Enoxaparin
- Lead sponsor: Monash Medical Centre
- Lead sponsor class: OTHER
- Collaborator: Southern Health, Victoria
- Collaborator class: UNKNOWN
- Collaborator: Eastern Health, Victoria
- Collaborator class: UNKNOWN
- Collaborator: Royal Adelaide Hospital
- Collaborator class: OTHER
- Collaborator: Prince of Wales Hospital, Sydney
- Collaborator class: OTHER\_GOV
- Collaborator: Christchurch Hospital
- Collaborator class: OTHER
- Collaborator: Auckland City Hospital
- Collaborator class: OTHER\_GOV
- Collaborator: North Shore Hospital, New Zealand
- Collaborator class: OTHER
- Collaborator: Middlemore Hospital, New Zealand
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry intervention name matches this record: Enoxaparin (`core:enoxaparin`)
- Registry lists this organization as a collaborator: Auckland City Hospital (`cardio:org-auckland-city-hospital`)

## Provenance

Content hash: 8c05b7f94e3977e1bf9b81ed0b9ac957d1a27ba147e6ec3044e7aa2760bb65d2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
